Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer
This study aim is to find out what effects capecitabine, oxaliplatin and radiation therapy following photodynamic therapy have on esophageal cancer.
Esophageal Neoplasm
DRUG: HPPH 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a)
Determine the toxicity of sequential PDT and chemoradiation in obstructing esophageal cancer, 2 year
Evaluate the efficacy of PDT in palliation of dysphagia, 2 years
This study aim is to find out what effects capecitabine, oxaliplatin and radiation therapy following photodynamic therapy have on esophageal cancer.